A randomised trial of granulocyte-macrophage colony-stimulating, factor for neonatal sepsis: outcomes at 2 years

COUNTER-compliant statistics provided by IRUS-UK.
Unless otherwise indicated, items in Spiral are protected by copyright and are licensed under a Creative Commons Attribution NonCommercial NoDerivatives License.